The clinical impact of magnetic resonance imaging in diagnosing focal hepatic lesions and suspected cancer.
To compare the clinical utility of contrast enhanced magnetic resonance imaging (MRI) to ultrasound (USS) and computed tomography (CT) in focal hepatic lesions (FHLs) This retrospective study analysed 125 consecutive iron oxide enhanced (SPIO) MRI. MRI made a difference in 74% of patients who had USS and in 42% of patients who had a CT scan. In suspected cancer, MRI changed diagnosis in 58% and 37% (13/35), respectively. MRI is superior to other noninvasive imaging modalities for lesion identification and characterisation.